What is Vertex Pharmaceuticals's change in AP?

Vertex Pharmaceuticals (VRTX) reported change in AP of $35.6M in Q1 2026.

How has Vertex Pharmaceuticals's change in AP changed year-over-year?

Vertex Pharmaceuticals's change in AP increased by 35.9% year-over-year, from $26.2M to $35.6M.

What is the long-term trend for Vertex Pharmaceuticals's change in AP?

Over 4 years (2021 to 2025), Vertex Pharmaceuticals's change in AP has grown at a 3.6% compound annual growth rate (CAGR), from $31.9M to $36.8M.

What does change in AP mean?

Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.

Vertex Pharmaceuticals VRTX Change in AP

Change in AP at other companies

Lexicon PharmaceuticalsLXRX

-$6.9M+68.2%

Travere Therapeutics, Inc.TVTX

-$11.81M-42.2%

Agios PharmaceuticalsAGIO

-$4.99M-77.0%

AbbVieABBV

-$1.59B-129%

4D Molecular TherapeuticsFDMT

$3.53M+1,603%

Beam TherapeuticsBEAM

$2.22M-41.6%

Other financials

Income statement

See full

Revenue$3.0B+7.8%

Gross profit$2.6B+7.8%

Operating income$1.1B+80.6%

Net income$1.0B+59.6%

EPS (diluted)$4.02+61.4%

Balance sheet

See full

Cash & equivalents$5.5B+17.5%

Total debt$2.0B+20.5%

Total equity$19.4B+17.4%

Total assets$26.5B+15.8%

Cash flow

See full

Operating cash flow$1.4B+74.4%

CapEx$133.4M+228%

Free cash flow$1.3B+66.4%

Valuation

See full

Market cap$126.07B+10.7%

Enterprise value$122.55B+11.0%

P/E29.1×—

P/S10.3×+0.3×

Profitability

See full

Gross margin86.2%+0.2pp

Operating margin38.3%—

Net margin35.5%—

FCF margin30.4%+20.2pp

Returns & leverage

See full

Return on equity24.2%—

Debt / equity0.1×0.0×

Current ratio3×+0.4×

Where this comes from

Reported directly by Vertex Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.

The official record: Vertex Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vertex Pharmaceuticals's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Vertex Pharmaceuticals's change in AP?: Vertex Pharmaceuticals (VRTX) reported change in AP of $35.6M in Q1 2026.
How has Vertex Pharmaceuticals's change in AP changed year-over-year?: Vertex Pharmaceuticals's change in AP increased by 35.9% year-over-year, from $26.2M to $35.6M.
What is the long-term trend for Vertex Pharmaceuticals's change in AP?: Over 4 years (2021 to 2025), Vertex Pharmaceuticals's change in AP has grown at a 3.6% compound annual growth rate (CAGR), from $31.9M to $36.8M.
What does change in AP mean?: Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.